Warberg Asset Management’s NeuroSense Therapeutics Ltd. Warrant NRSNW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,000
| Closed | -$2.05K | – | 185 |
|
|
2025
Q1 | $2.05K | Sell |
10,000
-7,936
| -44% | -$1.63K | ﹤0.01% | 157 |
|
|
2024
Q4 | $7.89K | Sell |
17,936
-2,265
| -11% | -$997 | ﹤0.01% | 138 |
|
|
2024
Q3 | $3.43K | Sell |
20,201
-11,805
| -37% | -$2.01K | ﹤0.01% | 148 |
|
|
2024
Q2 | $6.59K | Sell |
32,006
-9,400
| -23% | -$1.94K | ﹤0.01% | 152 |
|
|
2024
Q1 | $17.4K | Sell |
41,406
-22,096
| -35% | -$9.28K | ﹤0.01% | 129 |
|
|
2023
Q4 | $4.96K | Sell |
63,502
-12,607
| -17% | -$985 | ﹤0.01% | 156 |
|
|
2023
Q3 | $11K | Sell |
76,109
-1,600
| -2% | -$232 | ﹤0.01% | 142 |
|
|
2023
Q2 | $15.4K | Sell |
77,709
-56
| -0.1% | -$11 | ﹤0.01% | 133 |
|
|
2023
Q1 | $30.3K | Sell |
77,765
-1,903
| -2% | -$741 | 0.01% | 126 |
|
|
2022
Q4 | $14.4K | Sell |
79,668
-2,232
| -3% | -$403 | ﹤0.01% | 162 |
|
|
2022
Q3 | $19K | Buy |
81,900
+4,800
| +6% | +$1.11K | ﹤0.01% | 173 |
|
|
2022
Q2 | $39K | Buy |
77,100
+53,104
| +221% | +$26.9K | 0.01% | 128 |
|
|
2022
Q1 | $14K | Sell |
23,996
-42,610
| -64% | -$24.9K | ﹤0.01% | 171 |
|
|
2021
Q4 | $61K | Buy |
+66,606
| New | +$61K | 0.01% | 121 |
|